Ben R Taylor insider trades

Open-market stock purchases and sales by Ben R Taylor, Chief Financial Officer at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 22, 2017.

Recent trades

DateStockTradeValue
Sep 15, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$18.4K
Aug 17, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$79.1K
Jun 15, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$17K
May 15, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$76.1K
Apr 6, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$149K
Mar 17, 2026RXRX Recursion Pharmaceuticals, IncSold$27K
Mar 16, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$24.2K
Feb 18, 2026RXRX Recursion Pharmaceuticals, IncSold$41.4K
Feb 17, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$41.6K
Feb 6, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Feb 6, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Feb 6, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$45.4K
Dec 29, 2025RXRX Recursion Pharmaceuticals, IncSold$89.4K
Dec 15, 2025RXRX Recursion Pharmaceuticals, IncSold (not open market)$30.6K
Nov 25, 2025RXRX Recursion Pharmaceuticals, IncSold (not open market)$9.2K
Nov 17, 2025RXRX Recursion Pharmaceuticals, IncSold (not open market)$49.3K

Companies traded

  • RXRX Recursion Pharmaceuticals, Inc: 3 sales, last Sep 15, 2026
  • TYME Tyme Technologies, Inc: 1 buy, last May 7, 2020

Get free alerts when Ben R Taylor files a new trade →